Erik T Price, MD
Interventional Cardiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 7
Offices
7 locations · Stanford Health Care · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Price’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A69663 · Current
Licensed to practise in California · since 1999 · expires 2026-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$138,005
Medicare paid this office $138,005 for 971 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 408 | $84,774 | $110 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $13,077 | $467 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 72 | $11,929 | $149 |
| New patient visit (45+ min) | 69 | $10,421 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 298 | $3,806 | $12 |
See all 10 services
| Return visit (30+ min) | 408 | $84,774 | $110 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $13,077 | $467 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 72 | $11,929 | $149 |
| New patient visit (45+ min) | 69 | $10,421 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 298 | $3,806 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 78 | $1,780 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 77 | $995 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 95 | $864 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $247 | $9 |
| Blood test, clotting time | 19 | $126 | $4 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 39 | More than 74% of doctors who do this |
Who their Medicare patients are
971 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 17% · Women 40% · Also on Medicaid 7% · Health risk score 1.13. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 73% · Coronary heart disease 53% · Atrial fibrillation 29% · Chronic kidney disease 23% · Diabetes 22% · Heart failure 19% · Cancer 17% · Depression 15% · COPD 10% · Stroke 8% · Dementia 7%.
The office billed $527,194, Medicare allowed $189,838 and paid $138,005; for 1,686 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 971 | 1,686 | 77 | 1.13 | $527,194 | $138,005 |
| 2023 | 905 | 1,587 | 77 | 1.22 | $475,963 | $126,687 |
| 2022 | 914 | 1,755 | 77 | 1.04 | $471,001 | $134,198 |
| 2021 | 673 | 1,141 | 77 | 0.94 | $287,041 | $91,348 |
| 2020 | 623 | 1,199 | 77 | 1.10 | $298,694 | $86,179 |
| 2019 | 992 | 2,023 | 77 | 1.15 | $528,810 | $157,320 |
| 2018 | 858 | 1,328 | 76 | 1.10 | $385,560 | $109,715 |
| 2017 | 977 | 1,555 | 76 | 1.14 | $573,769 | $151,086 |
| 2016 | 1,017 | 1,694 | 76 | 1.12 | $672,686 | $176,644 |
| 2015 | 1,130 | 1,805 | 76 | 1.17 | $709,701 | $183,831 |
| 2014 | 1,158 | 1,881 | 76 | 1.08 | $790,001 | $185,811 |
| 2013 | 1,054 | 1,718 | 75 | 1.11 | $789,687 | $172,408 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 401 | $74,541 | $109 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $13,267 | $474 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 58 | $10,517 | $150 |
| New patient visit (45+ min) | 48 | $6,887 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 251 | $3,295 | $13 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,803 | $255 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 49 | $1,172 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $1,010 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $965 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 49 | $652 | $13 |
| Blood test, clotting time | 19 | $315 | $4 |
2022: 13 services
| Return visit (30+ min) | 369 | $73,965 | $111 |
| New patient visit (45+ min) | 101 | $13,772 | $136 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 75 | $12,989 | $169 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $12,723 | $509 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 309 | $3,948 | $12 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,269 | $251 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 66 | $1,795 | $22 |
| Anticoagulant management of patient taking warfarin | 37 | $843 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 84 | $831 | $8 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 25 | $627 | $25 |
| Blood test, clotting time | 38 | $538 | $4 |
| Heart rhythm recording of continous external ekg over 8-15 days | 25 | $393 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 29 | $325 | $11 |
2021: 10 services
| Return visit (30+ min) | 309 | $56,835 | $117 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,284 | $486 |
| New patient visit (45+ min) | 38 | $6,135 | $161 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 29 | $5,520 | $158 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 214 | $3,088 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 62 | $2,406 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 37 | $938 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 36 | $602 | $17 |
| Blood test, clotting time | 53 | $468 | $4 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $287 | $13 |
2020: 11 services
| Return visit (30+ min) | 278 | $43,524 | $90 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 49 | $9,084 | $182 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,532 | $594 |
| New patient visit (45+ min) | 36 | $5,380 | $149 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $3,687 | $263 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 172 | $2,603 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,705 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 57 | $1,643 | $17 |
| Blood test, clotting time | 85 | $838 | $4 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $569 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 15 | $423 | $28 |
2019: 15 services
| Return visit (30+ min) | 344 | $57,415 | $94 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 37 | $19,883 | $497 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 100 | $17,681 | $158 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $12,955 | $810 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 14 | $8,659 | $577 |
| New patient visit (45+ min) | 44 | $6,232 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 372 | $5,890 | $15 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $5,392 | $270 |
| New patient visit (60+ min) | 23 | $4,313 | $188 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 103 | $4,054 | $21 |
| Blood test, clotting time | 131 | $1,768 | $4 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 13 | $897 | $69 |
| External ekg recording for more than 48 hours up to 21 days | 22 | $590 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $516 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $185 | $8 |
2018: 9 services
| Return visit (30+ min) | 345 | $57,327 | $91 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 67 | $11,926 | $170 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,083 | $472 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 407 | $6,371 | $15 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,250 | $568 |
| New patient visit (45+ min) | 40 | $5,455 | $136 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $5,149 | $271 |
| External ekg recording for more than 48 hours up to 21 days | 25 | $707 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 25 | $612 | $24 |
2017: 12 services
| Return visit (30+ min) | 326 | $57,515 | $89 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 33 | $17,984 | $450 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 81 | $14,392 | $162 |
| Ultrasound of both sides of head and neck blood flow | 69 | $12,965 | $188 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,702 | $558 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 428 | $6,341 | $15 |
| Ultrasound of leg arteries or artery grafts | 20 | $5,305 | $265 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $4,744 | $264 |
| New patient visit (45+ min) | 30 | $4,412 | $147 |
| Ultrasound study of arm and leg arteries | 37 | $2,556 | $69 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 11 | $2,028 | $184 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $958 | $80 |
2016: 13 services
| Return visit (30+ min) | 312 | $59,375 | $93 |
| Ultrasound of both sides of head and neck blood flow | 104 | $19,186 | $184 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 91 | $18,000 | $182 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $17,000 | $459 |
| Ultrasound of leg arteries or artery grafts | 39 | $8,035 | $196 |
| New patient visit (45+ min) | 54 | $8,017 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 434 | $6,648 | $15 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 24 | $6,336 | $264 |
| Ultrasound study of arm and leg arteries | 62 | $4,971 | $78 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 21 | $4,254 | $203 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 12 | $2,790 | $232 |
| Long return visit (40+ min) | 21 | $2,769 | $132 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $1,041 | $95 |
2015: 19 services
| Return visit (30+ min) | 316 | $63,952 | $101 |
| Ultrasound of both sides of head and neck blood flow | 80 | $16,636 | $205 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 67 | $12,941 | $185 |
| New patient visit (45+ min) | 69 | $11,036 | $160 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 517 | $8,266 | $16 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $8,221 | $514 |
| Ultrasound of leg arteries or artery grafts | 33 | $8,121 | $246 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 13 | $7,901 | $608 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 21 | $6,072 | $289 |
| Long return visit (40+ min) | 32 | $4,686 | $142 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 14 | $3,697 | $264 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $2,965 | $185 |
| Ultrasound study of arm and leg arteries | 36 | $2,939 | $82 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $2,907 | $208 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $2,016 | $88 |
| Ultrasound of one leg arteries or artery grafts | 12 | $1,969 | $151 |
| External ekg recording for more than 48 hours up to 21 days | 25 | $734 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 25 | $629 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $129 | $8 |
2014: 15 services
| Return visit (30+ min) | 286 | $57,479 | $93 |
| Ultrasound of both sides of head and neck blood flow | 107 | $20,048 | $186 |
| Long return visit (40+ min) | 81 | $11,967 | $129 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 56 | $11,540 | $178 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 36 | $8,771 | $237 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,669 | $433 |
| Ultrasound of leg arteries or artery grafts | 34 | $8,015 | $229 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 542 | $8,013 | $14 |
| New patient visit (45+ min) | 47 | $6,836 | $145 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 22 | $6,104 | $277 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $5,381 | $269 |
| Ultrasound study of arm and leg arteries | 48 | $3,912 | $82 |
| Complete ultrasound study of arm and leg arteries | 26 | $3,174 | $122 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,601 | $76 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 13 | $1,323 | $102 |
2013: 16 services
| Return visit (30+ min) | 247 | $46,509 | $94 |
| Ultrasound of both sides of head and neck blood flow | 103 | $19,603 | $187 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $12,758 | $473 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 53 | $10,796 | $180 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 46 | $9,207 | $188 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 72 | $8,853 | $82 |
| Complete ultrasound study of arm and leg arteries | 57 | $8,353 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 485 | $7,872 | $15 |
| Long return visit (40+ min) | 48 | $6,347 | $132 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 24 | $6,238 | $260 |
| New patient visit (45+ min) | 28 | $4,116 | $147 |
| Ultrasound of leg arteries or artery grafts | 20 | $4,021 | $191 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 14 | $3,220 | $230 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 14 | $2,494 | $178 |
| Ultrasound study of arm and leg arteries | 26 | $2,129 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $893 | $74 |
Medicaid work
$603 in 2024
Medicaid paid $603 for 46 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 46 | $603 |
| 2024 | 46 | 1 | 19 | $603 |
| 2023 | 66 | 1 | 36 | $796 |
| 2022 | 61 | 1 | 25 | $344 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 66 | $796 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 61 | $344 |
Drugs they prescribed that Part D paid
$281,677
Pharmacies billed $281,677 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,270) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
3,051 generic and 219 brand-name prescriptions · $281,677 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 96 | $132,978 | $1,385 |
| Jardiance | 16 | $22,879 | $1,430 |
| Entresto | 20 | $20,591 | $1,030 |
| Xarelto | 13 | $17,954 | $1,381 |
| Repatha Sureclick | 24 | $13,624 | $568 |
See all 30 drugs
| Eliquis | 96 | $132,978 | $1,385 |
| Jardiance | 16 | $22,879 | $1,430 |
| Entresto | 20 | $20,591 | $1,030 |
| Xarelto | 13 | $17,954 | $1,381 |
| Repatha Sureclick | 24 | $13,624 | $568 |
| Praluent | 23 | $12,219 | $531 |
| Atorvastatin | 639 | $7,025 | $11 |
| Metoprolol | 447 | $6,964 | $16 |
| Clopidogrel | 262 | $4,225 | $16 |
| Rosuvastatin | 217 | $3,521 | $16 |
| Amlodipine Besylate | 272 | $3,021 | $11 |
| Ezetimibe | 90 | $2,485 | $28 |
| Losartan | 187 | $2,352 | $13 |
| Lisinopril | 146 | $1,710 | $12 |
| Carvedilol | 121 | $1,142 | $9 |
| Valsartan | 19 | $1,013 | $53 |
| Metoprolol | 80 | $713 | $9 |
| Furosemide | 95 | $630 | $7 |
| Diltiazem 24hr Er (Cd) | 26 | $513 | $20 |
| Atenolol | 59 | $509 | $9 |
| Isosorbide Mononitrate Er | 32 | $493 | $15 |
| Benazepril | 21 | $433 | $21 |
| Simvastatin | 65 | $428 | $7 |
| Potassium Chloride | 26 | $391 | $15 |
| Hydrochlorothiazide | 49 | $273 | $6 |
| Pravastatin | 17 | $224 | $13 |
| Nitroglycerin | 17 | $217 | $13 |
| Losartan-Hydrochlorothiazide | 14 | $194 | $14 |
| Spironolactone | 20 | $141 | $7 |
| Lisinopril-Hydrochlorothiazide | 15 | $37 | $2 |
Year by year
| 2024 | 3,270 | 480 | 0% (0) | 7% | $281,677 |
| 2023 | 3,100 | 443 | 0% (0) | 7% | $269,345 |
| 2022 | 2,728 | 427 | 0% (0) | 6% | $199,308 |
| 2021 | 2,155 | 330 | 0% (0) | 5% | $123,775 |
| 2020 | 2,402 | 328 | 0% (0) | 6% | $126,656 |
| 2019 | 2,382 | 332 | 0% (0) | 7% | $104,517 |
| 2018 | 2,096 | 306 | 0% (0) | 8% | $80,555 |
| 2017 | 1,971 | 275 | 0% (0) | 14% | $77,537 |
| 2016 | 2,043 | 276 | 0% (0) | 15% | $77,889 |
| 2015 | 1,953 | 271 | 0% (0) | 19% | $61,253 |
| 2014 | 1,740 | 218 | 0% (0) | 19% | $62,946 |
| 2013 | 1,838 | 227 | None | 21% | $75,635 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Eliquis | 103 | $124,229 | $1,206 |
| Entresto | 18 | $22,192 | $1,233 |
| Xarelto | 11 | $18,149 | $1,650 |
| Jardiance | 12 | $12,131 | $1,011 |
| Praluent | 19 | $10,195 | $537 |
| Metoprolol | 459 | $9,144 | $20 |
| Atorvastatin | 624 | $7,624 | $12 |
| Clopidogrel | 256 | $5,151 | $20 |
| Rosuvastatin | 185 | $5,064 | $27 |
| Losartan | 172 | $3,215 | $19 |
| Ezetimibe | 63 | $2,672 | $42 |
| Amlodipine Besylate | 256 | $2,616 | $10 |
| Carvedilol | 106 | $1,414 | $13 |
| Lisinopril | 137 | $1,218 | $9 |
| Simvastatin | 76 | $877 | $12 |
| Metoprolol | 84 | $867 | $10 |
| Furosemide | 83 | $770 | $9 |
| Valsartan | 15 | $726 | $48 |
| Potassium Chloride | 26 | $607 | $23 |
| Isosorbide Mononitrate Er | 33 | $595 | $18 |
| Atenolol | 57 | $535 | $9 |
| Losartan-Hydrochlorothiazide | 18 | $505 | $28 |
| Diltiazem 24hr Er (Cd) | 25 | $363 | $15 |
| Benazepril | 12 | $323 | $27 |
| Pravastatin | 17 | $303 | $18 |
| Nitroglycerin | 17 | $205 | $12 |
| Hydrochlorothiazide | 50 | $141 | $3 |
2022: 21 drugs
| Eliquis | 105 | $114,272 | $1,088 |
| Metoprolol | 460 | $8,328 | $18 |
| Atorvastatin | 526 | $5,809 | $11 |
| Clopidogrel | 231 | $5,313 | $23 |
| Rosuvastatin | 132 | $5,023 | $38 |
| Ezetimibe | 52 | $2,976 | $57 |
| Amlodipine Besylate | 236 | $2,077 | $9 |
| Losartan | 139 | $2,071 | $15 |
| Carvedilol | 112 | $1,529 | $14 |
| Lisinopril | 127 | $1,235 | $10 |
| Metoprolol | 91 | $830 | $9 |
| Simvastatin | 78 | $656 | $8 |
| Potassium Chloride | 19 | $430 | $23 |
| Isosorbide Mononitrate Er | 13 | $406 | $31 |
| Furosemide | 60 | $375 | $6 |
| Hydrochlorothiazide | 48 | $354 | $7 |
| Nitroglycerin | 17 | $333 | $20 |
| Benazepril | 18 | $262 | $15 |
| Pravastatin | 14 | $238 | $17 |
| Atenolol | 42 | $203 | $5 |
| Losartan-Hydrochlorothiazide | 14 | $203 | $14 |
2021: 19 drugs
| Eliquis | 65 | $64,111 | $986 |
| Metoprolol | 351 | $7,342 | $21 |
| Atorvastatin | 406 | $5,814 | $14 |
| Rosuvastatin | 87 | $3,775 | $43 |
| Clopidogrel | 197 | $3,497 | $18 |
| Amlodipine Besylate | 181 | $2,042 | $11 |
| Ezetimibe | 34 | $1,968 | $58 |
| Carvedilol | 114 | $1,678 | $15 |
| Losartan | 110 | $1,642 | $15 |
| Potassium Chloride | 25 | $865 | $35 |
| Metoprolol | 68 | $601 | $9 |
| Simvastatin | 85 | $587 | $7 |
| Lisinopril | 102 | $574 | $6 |
| Furosemide | 48 | $417 | $9 |
| Benazepril | 17 | $374 | $22 |
| Atenolol | 39 | $337 | $9 |
| Pravastatin | 16 | $259 | $16 |
| Hydrochlorothiazide | 33 | $252 | $8 |
| Nitroglycerin | 12 | $209 | $17 |
2020: 23 drugs
| Eliquis | 56 | $43,288 | $773 |
| Metoprolol | 383 | $11,378 | $30 |
| Atorvastatin | 455 | $8,477 | $19 |
| Clopidogrel | 268 | $5,009 | $19 |
| Rosuvastatin | 78 | $4,162 | $53 |
| Amlodipine Besylate | 209 | $2,618 | $13 |
| Carvedilol | 135 | $1,971 | $15 |
| Losartan | 89 | $1,508 | $17 |
| Ezetimibe | 16 | $1,216 | $76 |
| Metoprolol | 85 | $1,098 | $13 |
| Lisinopril | 113 | $1,071 | $9 |
| Potassium Chloride | 27 | $865 | $32 |
| Simvastatin | 89 | $665 | $7 |
| Furosemide | 66 | $502 | $8 |
| Valsartan | 11 | $490 | $45 |
| Isosorbide Mononitrate Er | 19 | $444 | $23 |
| Nitroglycerin | 16 | $414 | $26 |
| Benazepril | 13 | $356 | $27 |
| Pravastatin | 19 | $354 | $19 |
| Atenolol | 39 | $349 | $9 |
| Amiodarone | 16 | $261 | $16 |
| Hydrochlorothiazide | 30 | $222 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $217 | $20 |
2019: 21 drugs
| Eliquis | 44 | $27,311 | $621 |
| Metoprolol | 361 | $10,744 | $30 |
| Atorvastatin | 469 | $9,603 | $20 |
| Rosuvastatin | 93 | $6,775 | $73 |
| Clopidogrel | 257 | $4,775 | $19 |
| Amlodipine Besylate | 209 | $2,361 | $11 |
| Carvedilol | 128 | $1,682 | $13 |
| Simvastatin | 124 | $1,298 | $10 |
| Losartan | 89 | $1,271 | $14 |
| Lisinopril | 112 | $1,238 | $11 |
| Potassium Chloride | 26 | $982 | $38 |
| Metoprolol | 60 | $910 | $15 |
| Furosemide | 75 | $902 | $12 |
| Pravastatin | 20 | $560 | $28 |
| Amiodarone | 17 | $499 | $29 |
| Isosorbide Mononitrate Er | 25 | $462 | $18 |
| Atenolol | 42 | $425 | $10 |
| Nitroglycerin | 16 | $307 | $19 |
| Hydrochlorothiazide | 26 | $265 | $10 |
| Losartan-Hydrochlorothiazide | 13 | $247 | $19 |
| Lisinopril-Hydrochlorothiazide | 11 | $99 | $9 |
2018: 21 drugs
| Metoprolol | 324 | $12,597 | $39 |
| Eliquis | 21 | $11,425 | $544 |
| Atorvastatin | 359 | $8,203 | $23 |
| Rosuvastatin | 66 | $6,013 | $91 |
| Clopidogrel | 220 | $4,283 | $19 |
| Amlodipine Besylate | 164 | $1,751 | $11 |
| Simvastatin | 120 | $1,169 | $10 |
| Carvedilol | 108 | $1,155 | $11 |
| Lisinopril | 100 | $955 | $10 |
| Losartan | 80 | $900 | $11 |
| Isosorbide Mononitrate Er | 33 | $870 | $26 |
| Potassium Chloride | 37 | $791 | $21 |
| Furosemide | 100 | $598 | $6 |
| Pravastatin | 19 | $517 | $27 |
| Metoprolol | 51 | $480 | $9 |
| Atenolol | 37 | $379 | $10 |
| Nitroglycerin | 19 | $369 | $19 |
| Hydrochlorothiazide | 39 | $304 | $8 |
| Klor-Con 10 | 17 | $267 | $16 |
| Amiodarone | 11 | $234 | $21 |
| Losartan-Hydrochlorothiazide | 13 | $195 | $15 |
2017: 24 drugs
| Metoprolol | 356 | $13,070 | $37 |
| Eliquis | 17 | $7,065 | $416 |
| Crestor | 16 | $6,310 | $394 |
| Atorvastatin | 260 | $5,885 | $23 |
| Rosuvastatin | 35 | $3,540 | $101 |
| Clopidogrel | 209 | $3,386 | $16 |
| Valsartan | 15 | $1,533 | $102 |
| Amlodipine Besylate | 135 | $1,328 | $10 |
| Carvedilol | 96 | $1,153 | $12 |
| Potassium Chloride | 42 | $1,150 | $27 |
| Simvastatin | 130 | $1,014 | $8 |
| Mexiletine | 11 | $896 | $81 |
| Lisinopril | 83 | $754 | $9 |
| Furosemide | 110 | $658 | $6 |
| Losartan | 61 | $646 | $11 |
| Isosorbide Mononitrate Er | 31 | $630 | $20 |
| Metoprolol | 57 | $466 | $8 |
| Atenolol | 41 | $316 | $8 |
| Nitroglycerin | 13 | $281 | $22 |
| Hydrochlorothiazide | 36 | $257 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $157 | $14 |
| Clonidine | 15 | $154 | $10 |
| Klor-Con M10 | 12 | $153 | $13 |
| Lovastatin | 18 | $83 | $5 |
2016: 26 drugs
| Crestor | 26 | $13,855 | $533 |
| Metoprolol | 351 | $11,580 | $33 |
| Atorvastatin | 255 | $6,152 | $24 |
| Clopidogrel | 243 | $4,874 | $20 |
| Xarelto | 12 | $4,236 | $353 |
| Valsartan | 11 | $2,665 | $242 |
| Amlodipine Besylate | 167 | $1,745 | $10 |
| Atacand Hct | 11 | $1,475 | $134 |
| Potassium Chloride | 48 | $1,225 | $26 |
| Simvastatin | 127 | $960 | $8 |
| Carvedilol | 83 | $888 | $11 |
| Furosemide | 117 | $831 | $7 |
| Lisinopril | 99 | $824 | $8 |
| Felodipine Er | 12 | $808 | $67 |
| Isosorbide Mononitrate Er | 38 | $636 | $17 |
| Metoprolol | 51 | $501 | $10 |
| Losartan | 47 | $486 | $10 |
| Atenolol | 43 | $472 | $11 |
| Warfarin | 18 | $467 | $26 |
| Omeprazole | 11 | $339 | $31 |
| Nitrostat | 12 | $337 | $28 |
| Hydrochlorothiazide | 38 | $219 | $6 |
| Clonidine | 15 | $197 | $13 |
| Lovastatin | 25 | $192 | $8 |
| Amiodarone | 15 | $132 | $9 |
| Irbesartan | 14 | $103 | $7 |
2015: 24 drugs
| Metoprolol | 346 | $14,008 | $40 |
| Crestor | 20 | $9,144 | $457 |
| Atorvastatin | 173 | $4,530 | $26 |
| Clopidogrel | 246 | $3,490 | $14 |
| Valsartan | 15 | $3,096 | $206 |
| Amlodipine Besylate | 202 | $1,575 | $8 |
| Simvastatin | 139 | $940 | $7 |
| Mexiletine | 12 | $897 | $75 |
| Carvedilol | 95 | $818 | $9 |
| Furosemide | 123 | $791 | $6 |
| Lisinopril | 106 | $750 | $7 |
| Isosorbide Mononitrate Er | 40 | $735 | $18 |
| Potassium Chloride | 42 | $724 | $17 |
| Digoxin | 14 | $663 | $47 |
| Metoprolol | 48 | $398 | $8 |
| Nitrostat | 17 | $343 | $20 |
| Warfarin | 12 | $334 | $28 |
| Spironolactone-Hctz | 11 | $324 | $29 |
| Losartan | 30 | $293 | $10 |
| Atenolol | 32 | $253 | $8 |
| Hydrochlorothiazide | 37 | $187 | $5 |
| Lovastatin | 16 | $163 | $10 |
| Amiodarone | 11 | $154 | $14 |
| Irbesartan | 13 | $86 | $7 |
2014: 22 drugs
| Metoprolol | 293 | $11,030 | $38 |
| Clopidogrel | 234 | $6,460 | $28 |
| Diovan | 17 | $5,468 | $322 |
| Atorvastatin | 133 | $4,388 | $33 |
| Crestor | 15 | $3,401 | $227 |
| Ranexa | 12 | $3,218 | $268 |
| Simvastatin | 150 | $1,504 | $10 |
| Isosorbide Mononitrate Er | 47 | $1,200 | $26 |
| Carvedilol | 72 | $963 | $13 |
| Amlodipine Besylate | 104 | $936 | $9 |
| Lisinopril | 103 | $919 | $9 |
| Digox | 25 | $818 | $33 |
| Pravastatin | 24 | $736 | $31 |
| Losartan | 33 | $511 | $15 |
| Furosemide | 120 | $490 | $4 |
| Mexiletine | 11 | $449 | $41 |
| Potassium Chloride | 23 | $386 | $17 |
| Metoprolol | 45 | $355 | $8 |
| Klor-Con M10 | 17 | $266 | $16 |
| Atenolol | 30 | $193 | $6 |
| Benazepril | 11 | $124 | $11 |
| Hydrochlorothiazide | 23 | $117 | $5 |
2013: 27 drugs
| Clopidogrel | 281 | $13,335 | $47 |
| Metoprolol | 284 | $10,333 | $36 |
| Diovan | 26 | $7,813 | $300 |
| Atorvastatin | 122 | $5,607 | $46 |
| Ranexa | 12 | $3,021 | $252 |
| Simvastatin | 177 | $1,813 | $10 |
| Toprol Xl | 15 | $1,398 | $93 |
| Losartan | 45 | $1,312 | $29 |
| Isosorbide Mononitrate Er | 38 | $1,286 | $34 |
| Carvedilol | 70 | $1,186 | $17 |
| Diltiazem Er | 12 | $1,142 | $95 |
| Amlodipine Besylate | 112 | $1,130 | $10 |
| Isosorbide Dinitrate | 17 | $1,109 | $65 |
| Lisinopril | 74 | $725 | $10 |
| Potassium Chloride | 25 | $667 | $27 |
| Furosemide | 127 | $548 | $4 |
| Ramipril | 15 | $376 | $25 |
| Metoprolol | 29 | $323 | $11 |
| Ranitidine | 14 | $312 | $22 |
| Klor-Con 10 | 12 | $297 | $25 |
| Pravastatin | 25 | $289 | $12 |
| Warfarin | 26 | $254 | $10 |
| Benazepril | 23 | $213 | $9 |
| Nitrostat | 16 | $185 | $12 |
| Spironolactone-Hctz | 11 | $185 | $17 |
| Atenolol | 21 | $151 | $7 |
| Hydrochlorothiazide | 33 | $115 | $3 |
Money from drug and device companies
$24,900 in 2024
| 2024 | 1 | 2 | $24,900 | $24,900 |
| 2023 | 2 | 3 | $29,550 | $29,773 |
| 2021 | 2 | 6 | None | $695 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | None | $24,900 | 2 payments
|
See all 2 published payments
| Edwards Lifesciences | Consulting · 2024-12-10 | None | $14,670 |
| Edwards Lifesciences | Consulting · 2024-12-09 | None | $10,230 |
See earlier years (2023, 2021)
2023: $29,773
| Edwards Lifesciences | None | $29,752 | 2 payments
|
| Amgen | Repatha | $22 | 1 payment
|
2021: $695
| Edwards Lifesciences | None | $672 | 5 payments
|
| Abbott Laboratories | Optis Coronary Imaging System | $23 | 1 payment
|
Professional record
- NPI
- 1770783177
- Licence
- CA A69663California A69663: Current · expires 2026-09-30
- Trained
- Stanford University School of Medicine, 1998
- Group
- Stanford Health Care · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-07-23
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301 · 87 Encina Ave, Palo Alto, CA, 94301